Fiona Walter

Proactive breast cancer risk assessment in primary care: a review based on the principles of screening.

Juliet A Usher-Smith, Sarah Hindmarch, David P French, Marc Tischkowitz, Sowmiya Moorthie, Fiona M Walter, Rebecca A Dennison, Francisca Stutzin Donoso, Stephanie Archer, Lily Taylor, Jon Emery, Stephen Morris, Douglas F Easton, Antonis C Antoniou

Journal article  |  2023  |  Br J Cancer

In the UK, the National Institute for Health and Care Excellence (NICE) recommends that women at moderate or high risk of breast c..

Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.

Evie Papavasiliou, Valerie A Sills, Natalia Calanzani, Hannah Harrison, Claudia Snudden, Erica di Martino, Andy Cowan, Dawnya Behiyat, Rachel Boscott, Sapphire Tan, Jennifer Bovaird, Grant D Stewart, Fiona M Walter, Yin Zhou

Journal article  |  2023  |  Cancers (Basel)

Evidence on the use of biomarkers to detect bladder cancer in the general population is scarce. This study aimed to systematically..

The CRISP Trial: RCT of a decision support tool for risk-stratified colorectal cancer screening

Jon Emery, Mark A Jenkins, Sibel Saya, Patty Chondros, Jasmeen Oberoi, Shakira Milton, Kitty Novy, Emily Habgood, Napin Karnchanachari, Marie Pirotta, Lyndal Trevena, Adrian Bickerstaffe, Richard de Abreu Lourenco, Crothers Anna, Driss Ait Ouakrim, Louisa Flander, James G Dowty, Fiona M Walter, Malcolm Clark, Sally Doncovio, et al.

Journal article  |  2023  |  British Journal of General Practice

Background: A risk-stratified approach to colorectal cancer (CRC) screening could result in more acceptable balance of benefits an..

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial.

Bhagabati Ghimire, Rebecca Landy, Roberta Maroni, Samuel G Smith, Irene Debiram-Beecham, Peter D Sasieni, Rebecca C Fitzgerald, Greg Rubin, Fiona M Walter, Jo Waller, undefined BEST3 Consortium, Judith Offman

Journal article  |  2023  |  BMC Gastroenterol

BACKGROUND: The Cytosponge is a cell-collection device, which, coupled with a test for trefoil factor 3 (TFF3), can be used to dia..

Agreement between patient's description of abdominal symptoms of possible upper gastrointestinal cancer and general practitioner consultation notes: a qualitative analysis of video-recorded UK primary care consultation data.

Victoria Hardy, Juliet Usher-Smith, Stephanie Archer, Rebecca Barnes, John Lancaster, Margaret Johnson, Matthew Thompson, Jon Emery, Hardeep Singh, Fiona M Walter

Journal article  |  2023  |  BMJ Open

INTRODUCTION: Abdominal symptoms are common in primary care but infrequently might be due to an upper gastrointestinal (UGI) cance..

How Timely Is Diagnosis of Lung Cancer? Cohort Study of Individuals with Lung Cancer Presenting in Ambulatory Care in the United States.

Monica Zigman Suchsland, Lesleigh Kowalski, Hannah A Burkhardt, Maria G Prado, Larry G Kessler, Meliha Yetisgen, Maggie A Au, Kari A Stephens, Farhood Farjah, Anneliese M Schleyer, Fiona M Walter, Richard D Neal, Kevin Lybarger, Caroline A Thompson, Morhaf Al Achkar, Elizabeth A Sarma, Grace Turner, Matthew Thompson

Journal article  |  2022  |  Cancers (Basel)

The diagnosis of lung cancer in ambulatory settings is often challenging due to non-specific clinical presentation, but there are ..

Cancer research across Africa: a comparative bibliometric analysis.

Miriam Mutebi, Grant Lewison, Ajay Aggarwal, Olusegun Isaac Alatise, Christopher Booth, Miska Cira, Surbhi Grover, Ophira Ginsburg, Julie Gralow, Serine Gueye, Benda Kithaka, T Peter Kingham, Lofti Kochbati, Jennifer Moodley, Sulma Ibrahim Mohammed, Alex Mutombo, Ntokozo Ndlovu, Christian Ntizimira, Groesbeck Preer Parham, Fiona Walter, et al.

Journal article  |  2022  |  BMJ Glob Health

INTRODUCTION: Research is a critical pillar in national cancer control planning. However, there is a dearth of evidence for countr..

The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care

Sibel Saya, Lucy Boyd, Patty Chondros, Mairead McNamara, Michelle King, Shakira Milton, Richard De Abreu Lourenco, Malcolm Clark, George Fishman, Julie Marker, Cheri Ostroff, Richard Allman, Fiona M Walter, Daniel Buchanan, Ingrid Winship, Jennifer McIntosh, Finlay Macrae, Mark Jenkins, Jon Emery

Journal article  |  2022  |  TRIALS

BACKGROUND: Polygenic risk scores (PRSs) can predict the risk of colorectal cancer (CRC) and target screening more precisely than ..

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence

Andrew Lee, Nasim Mavaddat, Alex P Cunningham, Tim Carver, Stephanie Archer, Fiona M Walter, Marc Tischkowitz, Jonathan Roberts, Juliet Usher-Smith, Jacques Simard, Marjanka K Schmidt, Peter Devilee, Vesna Zadnik, Hannes Jurgens, Emmanuelle Mouret-Fourme, Antoine De Pauw, Matti Rookus, Thea M Mooij, Paul PD Pharoah, Douglas F Easton, et al.

Journal article  |  2022  |  JOURNAL OF MEDICAL GENETICS

BACKGROUND: BOADICEA (Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm) for breast cancer and the..

The Achieving Self-directed Integrated Cancer Aftercare Intervention for Detection of Recurrent and Second Primary Melanoma in Survivors of Melanoma: Pilot Randomized Controlled Trial.

Peter Murchie, Lynda Constable, Susan Hall, William Brant, Julia Allan, Marie Johnston, Judith Masthoff, Amanda Lee, Shaun Treweek, Dolapo Ayansina, Charlotte Proby, Kaz Rahman, Fiona Walter, Nigel Burrows, Amer Durrani, Graeme Maclennan

Journal article  |  2022  |  JMIR Cancer

BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin self-examinations (TSSEs) by sur..